Infantile spasms: Treatment challenges

Current Treatment Options in Neurology

Volumn 14, Issue 4, 2012, Pages 322-331

  Watemberg, Nathan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

ACTH; Adrenocorticotropic hormone; Challenges; Corticosteroids; CP 115; Cryptogenic; Idiopathic; Infantile spasms; Ketogenic diet; Surgery; Tetracosactide; Topiramate; Treatment; Vigabatrin; West's syndrome; Zonisamide

Indexed keywords

ANTICONVULSIVE AGENT; CARISBAMATE; CORTICOSTEROID; CORTICOTROPIN; CPP 115; DEXAMETHASONE; ETIRACETAM; PENTOBARBITAL; PHENYTOIN; PREDNISONE; PYRIDOXAL 5 PHOSPHATE; RAPAMYCIN; TETRACOSACTIDE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ACNE; AGITATION; ARTICLE; BRAIN ATROPHY; BRAIN SURGERY; COMPARATIVE EFFECTIVENESS; CONFUSION; CUSHINGOID SYNDROME; DEPRESSION; DOSE RESPONSE; DROWSINESS; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; HORMONAL THERAPY; HUMAN; HYPERKINESIA; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; INFANTILE SPASM; INFECTION; INSOMNIA; IRRITABILITY; KETOGENIC DIET; LOW DRUG DOSE; MEMORY DISORDER; MULTIPLE CYCLE TREATMENT; MYOCLONUS; NONHUMAN; NYSTAGMUS; PATHOPHYSIOLOGY; PSYCHOSIS; RECOMMENDED DRUG DOSE; RETINA DISEASE; SEIZURE; SIDE EFFECT; SOMNOLENCE; UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT; VITAMIN SUPPLEMENTATION; VOMITING; WEIGHT GAIN;

EID: 84865861227     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-012-0181-x     Document Type: Article

References (39)

1. Commission on Pediatric Epilepsy of the International League Against Epilepsy: Workshop on infantile spasms. Epilepsia 1992;33:195.
2. Shields WD. Infantile spasms: Little seizures, BIG consequence. Epilepsy Curr. 2006;6:63-9
3. Infantile Spasms: Treatment Challenges Watemberg 329 3.
4. Fois A. Infantile spasm: Review of the literature and personal experience. Ital J Pediatr. 2010;36:15-24.
5. Kivity S, Lerman P, Ariel R, et al. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia. 2004;45:255-62.
6. Riikonen RS. Favourable prognostic factors with infantile spasms. Eur J Paediatr Neurol. 2010;14: 13-8.
7. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies. Report of the ILAE Commission on Classification and Terminology. Epilepsia. 2009;51:676-85.
8. Brna PM, Gordon KE, Doley JM, Wood EP. The epidemiology of infantile spasms. Can J Neurol Sci. 2001;309:12.
9. Chen L, Zhu M, Zhou H, Liang J. Clinical study of West syndrome with PS and late-onset epileptic spasms. Epilepsy Res. 2010;89:82-8.
10. Galanopoulo AS, Moshé SL. The epileptic hypothesis: Developmentally related arguments based on animal models. Epilepsia. 2009;50 Suppl 7:37-42.
11. Lux AL. Is hypsarrhythmia a form of nonconvulsive status epilepticus? Acta Neurol Scand. 2007;186:37-44.
12. Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol. 2011;45:355-67.
13. You SJ, Kim HD, Hang HC. Factors influencing the evolution of West syndrome to Lennox-Gastaut syndrome. Pediatr Neurol. 2009;41:111-3.
14. O'Callaghan FX, Lux AL, Darke K, et al. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: Evidence from the United Kingdom Infantile Spasms Study. Epilepsia. 2011;52:1359-64.
15. Pellock JM, Hracovy R, Shinnar S, et al. Infantile spasms: A U.S. consensus report. Epilepsia. 2010;51:2175-89. This is a timely review of all available data on the practical aspects of recognition and effective treatment on IS by a panel of US experts.
16. Fukuyama Y. The Japanese scheme of ACTH therapy in West syndrome. Epilepsia. 2010;51:2216-8.
17. Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev. 2008;8:CD001770.
18. Riikonen R. A European perspective: Comments on "a U.S. consensus report". Epilepsia. 2010;51:2215-6.
19. Hong AM, Turner Z, Hamdy RF, Kossof EH. Infantile spasms treated with the ketogenic diet: Prospective single-center experience in 104 consecutive infants. Epilepsia. 2010;51:1403-7.
20. Kang HC, Lee YJ, Lee JS, et al. Comparison of shortversus long-term ketogenic diet for intractable infantile spasms. Epilepsia. 2011;52:781-7.
21. Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified Atkins diet in infantile spasms refractory to first-line treatment. Seizure. 2012;21:45-8.
22. Numis AL, Yellen MB, Chu-Shore CJ, et al. The relationship of ketosis and growth to the efficacy of the ketogenic diet in infantile spasms. Epilepsy Res. 2011;96:172-5.
23. Silverman SB. The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-Amino-4-difluoromethylenyl-1- cyclopentanoic Acid (CPP-115), a GABA Aminotransferase inactivator and new treatment for drug addiction and infantile spasms. J Med Chem. 2012;26:567-75. This article reports on the efficacy and safety of a novel compound that acts in a similar way to VGB, but at a much lower dose, and has been shown to be effective for IS in rat models. Given its much safer profile than that of VGB, CPP-115 was granted orphan drug status by the FDA. This development may be a landmark for safer, effective future treatment of IS.
24. Ono T, Moshé SL, Galanopoulou AS. Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms in rats. Epilepsia. 2011;52:1678-84.
25. Raffo E, Coppola A, Ono T, et al. A pulse rapamycin therapy for infantile spasms and associated cognitive decline. Neurobiol Dis. 2011;43:322-9.
26. Mackay MT, Weiss SK, Adams-Weber T, et al. Practice parameter: Medical treatment of infantile spasms: Report of the American Academy of Neurology and the Child Neurology Society. Neurology. 2004;62:1668-81.
27. Wray CD, Benke TA. Effect of price increase of adrenocorticotropic hormone on treatment practices of infantile spasms. Pediatr Neurol. 2010;43:163-6.
28. Zou LP, Wang X, Dong CH. Three-week combination treatment with ACTH+magnesium sulfate versus ACTH monotherapy for infantile spasms: A 24-week, randomized, open-label, follow-up study in China. Clin Ther. 2010;32:692-700.
29. Lerner JT, Salamon N, Sankar R. Clinical profile of vigabatrin as monotherapy for infantile spasms. Neuropsychiatr Dis Treat. 2010;6:731-40.
30. Vigevano F, Cilio MR. Vigabatrine versus ACTH as first-line treatment for infantile spasms: A randomized, prospective study. Epilepsia. 1997;38:1270-4.
31. Lux AL, Edwards SW, Hancock EC, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: A multicentre, randomised controlled trial. Lancet Neurol. 2005;4:712-7.
32. Cohen-Sadan S, Kramer U, Ben-Zeev B, et al. Multicenter long-term follow-up of children with idiopathic West syndrome: ACTH vs. vigabatrin. Eur J Neurol. 2009;16:482-7.
33. Darke K, Edwards SW, Hancock E, et al. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: A mulicentre randomized trial. Arch Dis Child. 2010;95:382-6. This work provides important follow-up 4 years later on the initial 2004 cohort of UKISS patients that prospectively compared hormonal to VGB treatment in a randomized manner.
34. Kossoff EH, Hartman AL, Rubenstein JE, Vining EP. High-dose oral prednisolone for infantile spasms: An effective and less expensive alternative to ACTH. Epilepsy Behav. 2009;14:674-6.
35. Haberlandt E, Weger C, Sigl SB, et al. Adrenocorticotropic hormone versus pulsatile dexamethasone in the treatment of infantile epilepsy syndromes. Pediatr Neurol. 2010;42:21-7.
36. Zhu X, Chen O, Zhang D, et al. A prospective study on the treatment of infantile spasms with first-line topiramate followed by low-dose ACTH. Epilepsy Res. 2011;93:149-54.
37. Yum MS, Ko TS. Zonisamide in West syndrome: An open label study. Epileptic Disord. 2009;11:339-44.
38. Chugani H, Asano E, Sood S. Infantile spasms: Who are the ideal surgical candidates? Epilepsia. 2010;51 (Suppl1):94-6.
39. Harvey AS, Cross JH, Shinnar S, Mathern BW, ILAE Pediatric Epilepsy Taskforce. Defining the spectrum of international practice in pediatric epilepsy surgery patients. Epiepsia. 2008;49:146-55.